Results 301 to 310 of about 174,618 (333)
Pharmacological and Pathological Implications of Sigma-1 Receptor in Neurodegenerative Diseases. [PDF]
BiomedicinesDrewes N, Fang X, Gupta N, Nie D.
europepmc +1 more source
Corrigendum: Neuroprotection by cattle encephalon glycoside and ignotin beyond the time window of thrombolysis in ischemic stroke. [PDF]
Neural Regen Reseuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cerebrovascular Diseases, 2000
The current goal of acute stroke therapy is to restore cerebral perfusion and to protect cerebral tissue before the development of an irreversible damage. This latter is due to the duration and the severity of cerebral ischemia [1]. Recanalization operated by thrombolysis represents the most intuitive and effective treatment of acute cerebral ischemia.
MOSTARDINI C +5 more
openaire +4 more sources
The current goal of acute stroke therapy is to restore cerebral perfusion and to protect cerebral tissue before the development of an irreversible damage. This latter is due to the duration and the severity of cerebral ischemia [1]. Recanalization operated by thrombolysis represents the most intuitive and effective treatment of acute cerebral ischemia.
MOSTARDINI C +5 more
openaire +4 more sources